BackBiondvax Pharmaceuticals Overview

Biondvax Pharmaceuticals Current Assets

Biondvax Pharmaceuticals's current assets is $7.8M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$7.77M
↓ 80.64% YoYΔ $-32.35M vs prior year quarter

Peer trimmed avg / median

Loading

Biondvax Pharmaceuticals Current Assets History

Loading

Biondvax Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Biondvax Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biondvax Pharmaceuticals (BVXV) FAQ

As of the most recent data (June 2023), BVXV shows a current assets of $7.8M. That compares with $40M in the prior-year period — down 80.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BVXV's current assets is now $7.8M (was $40M) — a 80.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biondvax Pharmaceuticals is outperforming or lagging.

Tracking BVXV's current assets over time shows whether Biondvax Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8M That compares with $40M in the prior-year period — down 80.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Biondvax Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $7.8M) with ownership activity and broader fundamentals.

Biondvax Pharmaceuticals's current assets is $7.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.